BMY Articles, Bristol-Myers Squibb Company - From 04/25/24

Thursday, Bristol Myers Squibb & Co (NYSE:BMY) posted first-quarter revenues of $11.9 billion, beating the consensus of $11.5 billion...

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NA...

Shares of Swiss pharma giant Novartis AG (NYSE:NVS) after the company raised its full-year guidance following better-than-expected first-quarter...

As the market runs into rough weather, the importance of the upcoming week’s earnings cannot be emphasized enough. A lot is riding on the ear...

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings??...

Friday, Agenus Inc (NASDAQ:AGEN) released updated results from its Phase 1 clinical trial of botensilimab and balstilimab (BOT/BAL) combi...

Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE: JNJ) a...

Monday, Bristol Myers Squibb & Co (NYSE:BMY) released data from the cohorts of the Phase 1/ 2 KRYSTAL-1 study evaluating Krazati (ada...

Saturday, Bristol Myers Squibb & Co (NYSE:BMY) released interim long-term safety, tolerability, and metabolic outcomes data from its ...

Friday, the FDA approved Bristol-Myers Squibb Company (NYSE:BMY) and  2seventy Bio Inc’s (NASDAQ:TSVT) Abecma&n...